VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin
Publication
, Journal Article
Gibson, CM; Harrington, RA; Goldhaber, SZ; Hernandez, AF; Hull, RD; Wiens, BL; Gold, A; Cohen, AT
Published in: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
May 1, 2016
Duke Scholars
Published In
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
EISSN
1538-7836
ISSN
1538-7933
Publication Date
May 1, 2016
Volume
14
Start / End Page
8 / 9
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Gibson, C. M., Harrington, R. A., Goldhaber, S. Z., Hernandez, A. F., Hull, R. D., Wiens, B. L., … Cohen, A. T. (2016). VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14, 8–9.
Gibson, C. M., R. A. Harrington, S. Z. Goldhaber, A. F. Hernandez, R. D. Hull, B. L. Wiens, A. Gold, and A. T. Cohen. “VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin.” JOURNAL OF THROMBOSIS AND HAEMOSTASIS 14 (May 1, 2016): 8–9.
Gibson CM, Harrington RA, Goldhaber SZ, Hernandez AF, Hull RD, Wiens BL, et al. VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2016 May 1;14:8–9.
Gibson, C. M., et al. “VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin.” JOURNAL OF THROMBOSIS AND HAEMOSTASIS, vol. 14, WILEY-BLACKWELL, May 2016, pp. 8–9.
Gibson CM, Harrington RA, Goldhaber SZ, Hernandez AF, Hull RD, Wiens BL, Gold A, Cohen AT. VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. WILEY-BLACKWELL; 2016 May 1;14:8–9.
Published In
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
EISSN
1538-7836
ISSN
1538-7933
Publication Date
May 1, 2016
Volume
14
Start / End Page
8 / 9
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology